CoChat

In Vitro Cultured Melissa officinalis Cells as Effective Ingredient to Protect Skin against Oxidative Stress, Blue Light, and Infrared Irradiations Damages

Open access
Pressi, Giovanna, Bertaiola, Oriana, Guarnerio, Chiara, Barbieri, Elisa, Guzzo, Flavia, Durand, Caroline, Peno-Mazzarino, Laurent, Cocetta, Veronica, Giacomini, Isabella, Semenzato, Alessandra · 2021 · Cosmetics

The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

Skin is being increasingly exposed to artificial blue light due to the extensive use of electronic devices, which can induce cell oxidative stress, causing signs of early photo aging. The Melissa officinalis phytocomplex is a new standardized cosmetic ingredient obtained by an in vitro plant cell culture with a high content of rosmarinic acid. In this study, we examine the activity of the Melissa officinalis phytocomplex to protect skin against blue light and infrared damages, evaluating the ROS (Radical Oxygen Species) level in keratinocyte cell line from human skin (HaCaT) and Nrf2 (Nuclear factor erythroid 2-related factor 2), elastin, and MMP1 (Matrix Metalloproteinase 1) immunostaining in living human skin explants ex vivo. This phytocomplex demonstrates antioxidant activity by reducing ROS production and thus the oxidant damage of the skin caused by UV and blue light exposure. In addition, it inhibits blue light-induced Nrf2 transcriptional activity, IR-induced elastin alteration, and IR-induced MMP-1 release. This Melissa officinalis phytocomplex is a new innovative active ingredient for cosmetic products that is able to protect skin against light and screen exposure damages and oxidative stress.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cosmetics8010023

Cites

27 of 28 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Melissa officinalis cell culture maintained in solid MO medium: ( a ) cells of the Melissa officinalis seen under an AXIO-Imager A2 optical microscope (ZEISS), in the bright field mode ( b ) and after staining with fluorescein diacetate ( c ).
Figure 1 Melissa officinalis cell culture maintained in solid MO medium: ( a ) cells of the Melissa officinalis seen under an AXIO-Imager A2 optical microscope (ZEISS), in the bright field mode ( b ) and after staining with fluorescein diacetate ( c ).CC-BY · From the PDF
Image 2
CC-BY · From the PDF
Figure 2 Chromatographic profile of the Melissa officinalis phytocomplex. The main peak at retention time of 7.3 min corresponds to rosmarinic acid. Figure 2. Chromatographic profile of the Melissa officinalis phytocomplex. The main peak at retention time of 7.3 min corresponds to rosmarinic acid. 3.2. Melissa officinalis Phytocomplex Exhibits Strong Inhibition of ROS Production afte
Figure 2 Chromatographic profile of the Melissa officinalis phytocomplex. The main peak at retention time of 7.3 min corresponds to rosmarinic acid. Figure 2. Chromatographic profile of the Melissa officinalis phytocomplex. The main peak at retention time of 7.3 min corresponds to rosmarinic acid. 3.2. Melissa officinalis Phytocomplex Exhibits Strong Inhibition of ROS Production afteCC-BY · From the PDF
Figure 3 ROS (Radical Oxygen Species) levels in HaCaT cells after 24 h treatment with the Melissa officinalis phytocomplex 0.1% w / v , NAC (N-Acetyl-L-Cysteine) 5 mM and Rutin 0.1% w / v . ROS were detected by diacetylated 2 ′ ,7 ′ -dichlorofluorescein (DCF-DA) staining at basal condition and following the exposure to oxidative stimulus H2O2. The fluorescence was measured by using a Victor3X multilabel plate counter (Ex 485 nm and Em 535 nm). Results are expressed as fold change of ROS production compared to control. Each bar represents the mean ± SD of n = 3 experiments. * p < 0.05, ** p < 0.01, *** p < 0.001, treatment vs. basal control. $$$ p < 0.001, treatment vs. stimulated control.
Figure 3 ROS (Radical Oxygen Species) levels in HaCaT cells after 24 h treatment with the Melissa officinalis phytocomplex 0.1% w / v , NAC (N-Acetyl-L-Cysteine) 5 mM and Rutin 0.1% w / v . ROS were detected by diacetylated 2 ′ ,7 ′ -dichlorofluorescein (DCF-DA) staining at basal condition and following the exposure to oxidative stimulus H2O2. The fluorescence was measured by using a Victor3X multilabel plate counter (Ex 485 nm and Em 535 nm). Results are expressed as fold change of ROS production compared to control. Each bar represents the mean ± SD of n = 3 experiments. * p < 0.05, ** p < 0.01, *** p < 0.001, treatment vs. basal control. $$$ p < 0.001, treatment vs. stimulated control.CC-BY · From the PDF
Image 5
CC-BY · From the PDF
Image 6
CC-BY · From the PDF
Figure 4 Cell viability of the untreated control on day 6 ( a ), of the batch treated with 0.05% w/w of the Melissa officinalis phytocomplex on day 6 ( b ) and of the batch treated with 0.1% w/w of Melissa officinalis phytocomplex on day 6 ( c ). Figure 4. Cell viability of the untreated control on day 6 ( a ), of the batch treated with 0.05% w / w of the Melissa officinalis phytocomplex on day 6 ( b ) and of the batch treated with 0.1% w / w of Melissa officinalis phytocomplex on day 6 ( c ). Figure 4. Cell viability of the untreated control on day 6 ( a ), of the batch treated with 0.05% w/w of the Melissa officinalis phytocomplex on day 6 ( b ) and of the batch treated with 0.1% w/w of Melissa officinalis phytocomplex on day 6 ( c ).
Figure 4 Cell viability of the untreated control on day 6 ( a ), of the batch treated with 0.05% w/w of the Melissa officinalis phytocomplex on day 6 ( b ) and of the batch treated with 0.1% w/w of Melissa officinalis phytocomplex on day 6 ( c ). Figure 4. Cell viability of the untreated control on day 6 ( a ), of the batch treated with 0.05% w / w of the Melissa officinalis phytocomplex on day 6 ( b ) and of the batch treated with 0.1% w / w of Melissa officinalis phytocomplex on day 6 ( c ). Figure 4. Cell viability of the untreated control on day 6 ( a ), of the batch treated with 0.05% w/w of the Melissa officinalis phytocomplex on day 6 ( b ) and of the batch treated with 0.1% w/w of Melissa officinalis phytocomplex on day 6 ( c ).CC-BY · From the PDF
Figure 5 Scoring of the Nrf2 immunostaining by microscopical examination on D6, on unexposed or blue light-exposed batches (BL). T is the untreated control, P1 and P2 are the batches treated with the Melissa officinalis phytocomplex at 0.05% and 0.1%, respectively.
Figure 5 Scoring of the Nrf2 immunostaining by microscopical examination on D6, on unexposed or blue light-exposed batches (BL). T is the untreated control, P1 and P2 are the batches treated with the Melissa officinalis phytocomplex at 0.05% and 0.1%, respectively.CC-BY · From the PDF
Figure 6 Nrf2 immunostaining of the batches irradiated with blue light ( a ), irradiated with blue light and pre-treated with the Melissa officinalis phytocomplex at 0.05% ( b ) or 0.1% w/v ( c ) on day 6. Figure 6. Nrf2 immunostaining of the batches irradiated with blue light ( a ), irradiated with blue light and pre-treated with the Melissa officinalis phytocomplex at 0.05% ( b ) or 0.1% w / v ( c ) on day 6. Figure 6. Nrf2 immunostaining of the batches irradiated with blue light ( a ), irradiated with blue light and pre-treated with the Melissa officinalis phytocomplex at 0.05% ( b ) or 0.1% w/v ( c ) on day 6.
Figure 6 Nrf2 immunostaining of the batches irradiated with blue light ( a ), irradiated with blue light and pre-treated with the Melissa officinalis phytocomplex at 0.05% ( b ) or 0.1% w/v ( c ) on day 6. Figure 6. Nrf2 immunostaining of the batches irradiated with blue light ( a ), irradiated with blue light and pre-treated with the Melissa officinalis phytocomplex at 0.05% ( b ) or 0.1% w / v ( c ) on day 6. Figure 6. Nrf2 immunostaining of the batches irradiated with blue light ( a ), irradiated with blue light and pre-treated with the Melissa officinalis phytocomplex at 0.05% ( b ) or 0.1% w/v ( c ) on day 6.CC-BY · From the PDF
Image 10
CC-BY · From the PDF
Figure 8 Elastin immunostaining in the papillary dermis of the batches irradiated with infrared on D6 ( a ), irradiated with infrared and pre-treated with the Melissa officinalis phytocomplex at 0.05% ( b ) or 0.1% w/v ( c ), on D6. Figure 8. Elastin immunostaining in the papillary dermis of the batches irradiated with infrared on D6 ( a ), irradiated with infrared and pre-treated with the Melissa officinalis phytocomplex at 0.05% ( b ) or 0.1% w / v ( c ), on D6.
Figure 8 Elastin immunostaining in the papillary dermis of the batches irradiated with infrared on D6 ( a ), irradiated with infrared and pre-treated with the Melissa officinalis phytocomplex at 0.05% ( b ) or 0.1% w/v ( c ), on D6. Figure 8. Elastin immunostaining in the papillary dermis of the batches irradiated with infrared on D6 ( a ), irradiated with infrared and pre-treated with the Melissa officinalis phytocomplex at 0.05% ( b ) or 0.1% w / v ( c ), on D6.CC-BY · From the PDF
Image 12
CC-BY · From the PDF
( a ) ( b ) ( c ) Figure 10. MMP-1 immunostaining in the papillary dermis of the batches irradiated with infrared on D6 ( a ), irradiated Figure 10. MMP-1 immunostaining in the papillary dermis of the batches irradiated with infrared on D6 ( a ), irradiated with infrared, and pre-treated with the Melissa officinalis phytocomplex at 0.05% ( b ) or 0.1% w/v ( c ) on D6. Figure 10. MMP-1 immunostaining in the papillary dermis of the batches irradiated with infrared on D6 ( a ), irradiated with infrared, and pre-treated with the Melissa officinalis phytocomplex at 0.05% ( b ) or 0.1% w / v ( c ) on D6.
( a ) ( b ) ( c ) Figure 10. MMP-1 immunostaining in the papillary dermis of the batches irradiated with infrared on D6 ( a ), irradiated Figure 10. MMP-1 immunostaining in the papillary dermis of the batches irradiated with infrared on D6 ( a ), irradiated with infrared, and pre-treated with the Melissa officinalis phytocomplex at 0.05% ( b ) or 0.1% w/v ( c ) on D6. Figure 10. MMP-1 immunostaining in the papillary dermis of the batches irradiated with infrared on D6 ( a ), irradiated with infrared, and pre-treated with the Melissa officinalis phytocomplex at 0.05% ( b ) or 0.1% w / v ( c ) on D6.CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Cited by

See all 17

Metadata

Authors
Pressi, G., Bertaiola, O., Guarnerio, C., Barbieri, E., Guzzo, F., Durand, C., Peno-Mazzarino, L., Cocetta, V., Giacomini, I., & Semenzato, A.
Affiliations
  • Demethra Biotech S.R.L., 36043 Camisano Vicentino (VI), Italy
  • University of Verona (IT)
  • Laboratoire BIO-EC, 91160 Longjumeau, France
  • University of Padua (IT)
  • Unired S.R.L, 35131 Padova, Italy
Corresponding author
  • Pressi, Giovanna
  • Barbieri, Elisa
Venue
Cosmetics
Publisher
MDPI AG
Published
2021-03-15
Volume
8
Issue
1
Pages
23
ISSN
2079-9284 (ISSN-L)
OpenAlex
W3139376022
Cited by
12
References
27
Citations by year
2026: 3 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 3
FWCI
1.77
Type
journal article
Language
en
Open access
Locations
  • Cosmetics (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Padua Research Archive (University of Padova) (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Dermatology › Skin Protection and Aging
  • Health Sciences › Medicine › Biochemistry (medical) › Phytochemicals and Antioxidant Activities
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
Keywords
lemon balm, phytocomplex, in vitro plant cell culture, rosmarinic acid, blue light damage, infrared radiation, oxidative stress, photoaging, antioxidant activity, reactive oxygen species, Nrf2, elastin, MMP-1, keratinocytes, cosmetic ingredients, skin explants

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.